Annual EBITDA:
-$104.24M-$21.00M(-25.24%)Summary
- As of today, ELVN annual EBITDA is -$104.24 million, with the most recent change of -$21.00 million (-25.24%) on December 31, 2024.
- During the last 3 years, ELVN annual EBITDA has fallen by -$79.59 million (-322.92%).
- ELVN annual EBITDA is now -332.82% below its all-time high of -$24.08 million, reached on December 1, 2019.
Performance
ELVN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$25.03M+$3.47M(+12.17%)Summary
- As of today, ELVN quarterly EBITDA is -$25.03 million, with the most recent change of +$3.47 million (+12.17%) on September 30, 2025.
- Over the past year, ELVN quarterly EBITDA has increased by +$1.95 million (+7.24%).
- ELVN quarterly EBITDA is now -668.62% below its all-time high of -$3.26 million, reached on December 31, 2022.
Performance
ELVN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$111.97M+$1.95M(+1.72%)Summary
- As of today, ELVN TTM EBITDA is -$111.97 million, with the most recent change of +$1.95 million (+1.72%) on September 30, 2025.
- Over the past year, ELVN TTM EBITDA has dropped by -$11.90 million (-11.89%).
- ELVN TTM EBITDA is now -1528.92% below its all-time high of -$6.87 million, reached on September 1, 2019.
Performance
ELVN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ELVN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -25.2% | +7.2% | -11.9% |
| 3Y3 Years | -322.9% | -130.2% | -161.7% |
| 5Y5 Years | -332.8% | -100.8% | -272.3% |
ELVN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -322.9% | at low | -668.6% | +20.8% | -252.8% | +1.7% |
| 5Y | 5-Year | -332.8% | at low | -668.6% | +20.8% | -272.3% | +1.7% |
| All-Time | All-Time | -332.8% | at low | -668.6% | +20.8% | -1528.9% | +1.7% |
ELVN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$25.03M(+12.2%) | -$111.97M(+1.7%) |
| Jun 2025 | - | -$28.50M(+9.9%) | -$113.93M(-3.6%) |
| Mar 2025 | - | -$31.62M(-17.9%) | -$109.95M(-5.5%) |
| Dec 2024 | -$104.24M(-25.2%) | -$26.82M(+0.6%) | -$104.24M(-4.2%) |
| Sep 2024 | - | -$26.99M(-10.0%) | -$100.07M(-2.9%) |
| Jun 2024 | - | -$24.52M(+5.3%) | -$97.25M(-4.8%) |
| Mar 2024 | - | -$25.91M(-14.4%) | -$92.79M(-11.5%) |
| Dec 2023 | -$83.23M(-147.4%) | -$22.65M(+6.3%) | -$83.23M(-30.4%) |
| Sep 2023 | - | -$24.17M(-20.5%) | -$63.84M(-26.3%) |
| Jun 2023 | - | -$20.06M(-22.7%) | -$50.54M(-28.1%) |
| Mar 2023 | - | -$16.35M(-402.0%) | -$39.45M(-24.3%) |
| Dec 2022 | -$33.65M | -$3.26M(+70.0%) | -$31.73M(+25.8%) |
| Sep 2022 | - | -$10.87M(-21.3%) | -$42.79M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$8.96M(-3.8%) | -$45.55M(+8.4%) |
| Mar 2022 | - | -$8.64M(+39.6%) | -$49.73M(+3.1%) |
| Dec 2021 | -$24.65M(+40.8%) | - | - |
| Dec 2021 | - | -$14.31M(-4.9%) | -$51.34M(-5.7%) |
| Sep 2021 | - | -$13.63M(-3.7%) | -$48.56M(-2.5%) |
| Jun 2021 | - | -$13.14M(-28.2%) | -$47.40M(-6.4%) |
| Mar 2021 | - | -$10.26M(+11.0%) | -$44.53M(-7.0%) |
| Dec 2020 | -$41.60M(-72.7%) | -$11.53M(+7.6%) | -$41.60M(-38.3%) |
| Sep 2020 | - | -$12.47M(-21.3%) | -$30.07M(-22.9%) |
| Jun 2020 | - | -$10.28M(-40.2%) | -$24.48M(-72.4%) |
| Mar 2020 | - | -$7.33M(-6.6%) | -$14.20M(-106.6%) |
| Dec 2019 | -$24.08M | - | - |
| Sep 2019 | - | -$6.87M | -$6.87M |
FAQ
- What is Enliven Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Enliven Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Enliven Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of ELVN is -$104.24M
What is the all-time high annual EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual EBITDA is -$24.08M
What is Enliven Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ELVN annual EBITDA has changed by -$21.00M (-25.24%)
What is Enliven Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ELVN is -$25.03M
What is the all-time high quarterly EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly EBITDA is -$3.26M
What is Enliven Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ELVN quarterly EBITDA has changed by +$1.95M (+7.24%)
What is Enliven Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ELVN is -$111.97M
What is the all-time high TTM EBITDA for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high TTM EBITDA is -$6.87M
What is Enliven Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ELVN TTM EBITDA has changed by -$11.90M (-11.89%)